Fluvoxamine

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

36 Suppliers, 13 USDMF, 1 CEP/COS, 7 JDMF, 4 EU WC, 6 NDC API, 22 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

INTERMEDIATES

6 Suppliers

6 Suppliers

DOSSIERs // Finished Dosage Forms

108 Dossiers, 61 FDA Orange Book, 22 Europe, 8 Canada, 8 Australia, 4 South Africa, 5 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE, EXTENDED RELEASE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 26 BASF, 20 Roquette, 17 Corel Pharma Chem, 17 SPI Pharma, 17 Kerry, 14 Seppic, 11 Microlex e.U, 10 Sigachi Industries, 10 Gangwal Chemicals, 10 Gangwal Healthcare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 Actylis, 6 Lonza Capsugel, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 4 Nanjing Well Pharmaceutical, 4 Kima Chemical, 4 ACG Worldwide, 4 Prachin Chemical, 4 Pharmatrans-Sanaq, 3 DFE Pharma, 3 Vasa Pharmachem, 3 The Dow Chemical Company, 3 DKSH, 2 Evonik, 2 Pfanstiehl, 2 Seqens, 2 Finar, 2 Vertellus, 2 Nomisma Healthcare, 2 Jai Radhe Sales, 2 Qualicaps, 1 Chynops Pharma, 1 Boai NKY Pharmaceuticals Ltd, 1 Alcedo Pharmachem, 1 Minakem, 1 Nanjing Bold Chemical, 1 Ulanqab Kema New Material, 1 Aeon Procare, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Clariant, 1 Shijiazhuang Huaxu Pharmaceutical, 1 NEWEDGE Overseas, 1 Rochem International Inc

EXCIPIENTS BY APPLICATIONS

61 Fillers, Diluents & Binders, 52 Coating Systems & Additives, 41 Controlled & Modified Release, 33 Direct Compression, 25 Solubilizers, 25 Thickeners and Stabilizers, 25 Disintegrants & Superdisintegrants, 22 Granulation, 22 Taste Masking, 21 Lubricants & Glidants, 17 Chewable & Orodispersible Aids, 17 Film Formers & Plasticizers, 14 Topical, 14 Parenteral, 13 Co-Processed Excipients, 9 Empty Capsules, 6 Emulsifying Agents, 6 API Stability Enhancers, 4 Rheology Modifiers, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 2 Coloring Agents

GLOBAL SALES INFORMATION

15 US Medicaid Prescriptions, 28 Finished Drug Prices

MARKET PLACE

14 APIs, 1 Intermediates

ANALYTICAL SOLUTION(s)

1 BioAnalytical Methods, 1 EDQM Standards, 1 USP Standards, 4 JP Standards, 1 Other Ref. Standards

DIGITAL CONTENT

15 News

15 News

Approved Marketing Authorisations (MA) containing Fluvoxamine in Europe. Original Data : EMA Website

Fluvoxamine

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

36 Suppliers

13 USDMF

1 CEP/COS

7 JDMF

4 EU WC

6 NDC API

22 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Imports

INTERMEDIATES

6 Suppliers

DOSSIERs // Finished Dosage Forms

108 Dossiers

61 FDA Orange Book

22 Europe

8 Canada

8 Australia

4 South Africa

5 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE, EXTENDED RELEASE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

26 BASF

20 Roquette

17 Corel Pharma Chem

17 SPI Pharma

17 Kerry

14 Seppic

11 Microlex e.U

10 Sigachi Industries

10 Gangwal Chemicals

10 Gangwal Healthcare

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

6 Actylis

6 Lonza Capsugel

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

5 Ideal Cures Pvt Ltd

4 Ingredion Pharma Solutions

4 Nanjing Well Pharmaceutical

4 Kima Chemical

4 ACG Worldwide

4 Prachin Chemical

4 Pharmatrans-Sanaq

3 DFE Pharma

3 Vasa Pharmachem

3 The Dow Chemical Company

3 DKSH

2 Evonik

2 Pfanstiehl

2 Seqens

2 Finar

2 Vertellus

2 Nomisma Healthcare

2 Jai Radhe Sales

2 Qualicaps

1 Chynops Pharma

1 Boai NKY Pharmaceuticals Ltd

1 Alcedo Pharmachem

1 Minakem

1 Nanjing Bold Chemical

1 Ulanqab Kema New Material

1 Aeon Procare

1 Qianhao Chemical (Hebei) Co., Ltd

1 Clariant

1 Shijiazhuang Huaxu Pharmaceutical

1 NEWEDGE Overseas

1 Rochem International Inc

EXCIPIENTS BY APPLICATIONS

CAPSULE, EXTENDED RELEASE;ORAL - 100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 150MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons